field brief · no. 001

Blue Lotus
Nymphaea caerulea

subject: aporphine alkaloids
routes covered: smoke · vapor · oral
rev.: 2026-07-04 · v1.0
prepared by: Herman
live source: blue-lotus.hermanity.dev

Plant at a glance

taxonomy · context

binomial	Nymphaea caerulea Savigny
family	Nymphaeaceae (water lily)
origin	Nile basin · naturalized elsewhere
common names	blue Egyptian lotus · blue water lily · sacred blue lily
often confused with	Nelumbo nucifera (Asian sacred lotus — different family)
parts used	flower petals, stamens (occasionally rhizome)
cultural record	Egyptian art, 14th c. BCE onward · Tutankhamun garlands (1922)

key distinction

Despite the shared English word "lotus," N. caerulea and Nelumbo nucifera are taxonomically and chemically distinct — only nuciferine is shared. The aporphine + bisbenzylisoquinoline (liensinine, neferine, nelumbine) alkaloid profiles are not interchangeable.

Two alkaloids, two mechanisms

pharmacology

nuciferine

aporphine · primary alkaloid

partial agonist D2 · D5
agonist D4 · 5-HT1A
antagonist 5-HT2A · 5-HT2C · 5-HT2B
inverse agonist 5-HT7
inhibits dopamine transporter (DAT)

dirty receptor modulator · atypical antipsychotic-like signals in rodent models · no human controlled trials

apomorphine

aporphine · trace in flower

non-selective agonist dopamine D1 · D2
agonist 5-HT1A · 5-HT2A · 5-HT2B · 5-HT2C
low affinity antagonist α-adrenergic · muscarinic · histamine H1

pharmaceutical apomorphine is dosed in milligrams for Parkinson's — flower concentrations are orders of magnitude lower; a 2023 GC-MS survey found it virtually absent in authenticated extracts

Smoke vs. vapor — kinetics

comparative

SMOKEcombustion of dried petals

onset

~1–5 min

peak

5–15 min

duration

~1–2 h

dose

0.5–2 g dried petal

bioavail.

variable · partial pyrolysis

lung load

combustion byproducts (CO, tars)

VAPORconduction · atomization of extract/resin

onset

~1–3 min

peak

5–10 min

duration

~30–90 min

dose

~50–200 mg resin/extract

bioavail.

higher — confirmed by aerosolization analysis

lung load

PG/VG aerosol · cleaner, not inert

Bars are qualitative, not numerically calibrated. nuciferine has been confirmed to aerosolize via rebuildable dripping atomizer (PMC 5638439); commercial extract composition varies widely — labeled concentrations are not reliable.

Dose ladder

dried petal · oral as reference

01
~1 g
threshold
subtle · most users feel nothing
02
~3 g
mild
gentle relaxation · anxiolysis
03
~5 g
regular
mild euphoria · sedation · dream vividness
04
~10 g
strong
pronounced psychoactive · hallucinations possible
05
> 10 g
over
side-effect probability rises sharply

smoke / vapor note

Inhalation doses are smaller — typically 0.5–2 g of dried flower or 50–200 mg of extract per session. Vapor extracts are often 10×–20× concentrated, making dose control the central difficulty of this route.

Side effects ledger

documented · case-report level

effect	severity	onset context	resolution
dry mouth	low	any dose, any route	self-resolves · hours
dizziness · ataxia	low	mild doses · especially vapor	self-resolves · hours
nausea · vomiting	mid	strong+ doses · oral concentrates	self-resolves · hours
slurred speech · drowsiness	mid	strong doses · combined with sedatives	self-resolves · hours
anxiety · agitation · paranoia	mid	paradoxical at higher doses	self-resolves · hours
chest pain	high	vapor concentrates (case reports)	medical eval recommended
confusion · disorientation	high	strong+ doses · naive users	self-resolves · hours
seizures	high	documented case (military)	emergency medical care
synthetic-cannabinoid contamination	high	adulterated commercial product	cannot predict — avoid unknown sources

No controlled-dose data exists. Frequency estimates are case-report based, not population-derived.

Legal map

as of mid-2026

US federal	legal · not DEA-scheduled · not FDA-approved for consumption
US states	legal in 49 + DC
Louisiana	banned — LA Rev. Stat. 40:989.1 (2011) · controlled dangerous substance
DoD / US military	prohibited — DoD Prohibited Dietary Supplement Ingredients list
Russia · Latvia · Poland	restricted / banned
FDA marketing	may not be sold as dietary supplement or food additive · only as botanical / aromatic

the Louisiana note

The only US state with a hard ban on possession, sale, and distribution. Reputable retailers block shipments to Louisiana — confirming shipping there is a legal hazard, not a gray area.

What we don't know

the honest section

No controlled human trials of blue lotus flower at any dose, for any indication.
No standardized extract — alkaloid concentration in commercial products varies by an order of magnitude or more.
No established drug-interaction profile — caution with alcohol, cannabis, sedatives, MAOIs, dopaminergic medications.
No reproductive-safety data — avoid in pregnancy, breastfeeding, or planning either.
No chronic-exposure data — repeated use over months has not been studied in humans.
Apomorphine bioavailability from inhalation vs. sublingual routes has not been characterized in human subjects.